Education
About Us
Working with TipRanks
Follow Us
Astrana Health (ASTH)
NASDAQ:ASTH
ASTH Stock Chart & Stats
$24.44
$0.06(0.19%)
At close: 4:00 PM EST
$24.44
$0.06(0.19%)
Day’s Range― - ―
52-Week Range$20.12 - $39.97
Previous CloseN/A
Volume92.25K
Average Volume (3M)571.60K
Market Cap
$1.20B
Enterprise Value$1.81B
Total Cash (Recent Filing)$463.45M
Total Debt (Recent Filing)$1.09B
Price to Earnings (P/E)128.6
Beta1.04
Next Earnings
Feb 19, 2026EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding50,155,613
10 Day Avg. Volume707,620
30 Day Avg. Volume571,600
Financial Highlights & Ratios
PEG Ratio-1.16
Price to Book (P/B)2.11
Price to Sales (P/S)0.74
P/FCF Ratio34.04
Enterprise Value/Market Cap1.50
Enterprise Value/Revenue0.62
Enterprise Value/Gross Profit6.14
Enterprise Value/Ebitda16.69
Forecast
1Y Price Target
$31.50Price Target Upside28.89% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)0.51
Revenue Forecast (FY)$3.16B
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAstrana Health reported solid third quarter 2025 results, with sales ahead of expectations and adjusted EBITDA topping the consensus forecast.
Growth OpportunitiesThe shift to risk, as well as organic growth opportunities in core and emerging markets, can underwrite 20%-30%+ growth long-term.
Strategic PartnershipsThe company announced a strategic partnership with Intermountain Health to expand its operations across southern Nevada.
Bears Say
Guidance RevisionManagement modestly lowered full-year guidance to account for contract-timing delays across several payer partners in the newly combined Astrana-Prospect Health business in California.
Investor ConfidenceThe FY26 EBITDA bar for ASTH is low and implies very little investor confidence in the full-risk contract conversion delays that management is assuming will be effective in 1Q26.
Price Target AdjustmentThe price target was moved from $40 to $35, based on a 2026 EV/EBITDA-NCI target of 10.6x.
Astrana Health News
ASTH FAQ
What was Astrana Health’s price range in the past 12 months?
Astrana Health lowest stock price was $20.12 and its highest was $39.97 in the past 12 months.
What is Astrana Health’s market cap?
Astrana Health’s market cap is $1.20B.
When is Astrana Health’s upcoming earnings report date?
Astrana Health’s upcoming earnings report date is Feb 19, 2026 which is in 56 days.
How were Astrana Health’s earnings last quarter?
Astrana Health released its earnings results on Nov 06, 2025. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.466 by -$0.456.
Is Astrana Health overvalued?
According to Wall Street analysts Astrana Health’s price is currently Undervalued.
Does Astrana Health pay dividends?
Astrana Health does not currently pay dividends.
What is Astrana Health’s EPS estimate?
Astrana Health’s EPS estimate is 0.09.
How many shares outstanding does Astrana Health have?
Astrana Health has 50,155,613 shares outstanding.
What happened to Astrana Health’s price movement after its last earnings report?
Astrana Health reported an EPS of $0.01 in its last earnings report, missing expectations of $0.466. Following the earnings report the stock price went down -23.441%.
Which hedge fund is a major shareholder of Astrana Health?
Currently, no hedge funds are holding shares in ASTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Astrana Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$31.50 (28.89% Upside)
$31.50 (28.89% Upside)
Blogger Sentiment
Bullish
ASTH Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 68.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.7%
Last 30 Days ▲ 1.4%
Last 30 Days ▲ 1.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-26.97%
12-Months-Change
Fundamentals
Return on Equity
1.29%
Trailing 12-Months
Asset Growth
74.05%
Trailing 12-Months
Company Description
Astrana Health
Astrana Health (ASTH) is a biotechnology company focused on developing innovative healthcare solutions that enhance patient outcomes. Operating primarily within the healthcare and pharmaceutical sectors, Astrana Health specializes in the research and development of novel therapeutics, diagnostic tools, and digital health platforms. The company's core products include advanced therapies targeting chronic illnesses and personalized medicine solutions, aimed at improving patient care and optimizing treatment efficacy.
ASTH Company Deck
ASTH Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Astrana Health's earnings call highlighted significant revenue and EBITDA growth, successful integration of Prospect Health, and technological advancements. However, delays in full risk contract transitions and potential Medicaid headwinds presented challenges. The positive aspects, including strong financial performance and strategic partnerships, were more prominent.View all ASTH earnings summariesASTH Stock 12 Month Forecast
Average Price Target
$31.50
▲(28.89% Upside)
Technical Analysis
Healthcare Services
―
Pediatrix Medical Group
―
Select Medical
―
US Physical Therapy
―
Aveanna Healthcare Holdings
―
Ownership Overview
47.30% Insiders
17.59% Mutual Funds
8.78% Other Institutional Investors
4.53% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---